Section 84 of the Indian Patents Act, which allows domestic companies to apply for compulsory licences, was recently tested for the first time by India’s Patents Office. Its March decision against Bayer Corporation has led many foreign pharmaceutical companies and patent holders in other industries to reconsider their India strategies
July 31 2012